Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin

被引:21
|
作者
Delort, Laetitia [1 ]
Bougaret, Lauriane [1 ]
Cholet, Juliette [1 ]
Vermerie, Marion [1 ]
Billard, Hermine [1 ]
Decombat, Caroline [1 ]
Bourgne, Celine [2 ]
Berger, Marc [2 ]
Dumontet, Charles [3 ]
Caldefie-Chezet, Florence [1 ]
机构
[1] Univ Clermont Auvergne, CRNH Auvergne, INRA, UNH, F-63000 Clermont Ferrand, France
[2] CHU Estaing, Serv Hematol Biol, F-63000 Clermont Ferrand, France
[3] Univ Lyon 1, INSERM U1052, CNRS 5286, Canc Res Ctr Lyon, F-69008 Lyon, France
关键词
breast cancer; adipose secretome; leptin; hormonal therapy resistance; cancer stem cells; ADIPOSE-TISSUE; ENDOCRINE THERAPY; STEM-CELLS; IDENTIFICATION; INTERLEUKIN-6; OBESITY; STAT3;
D O I
10.3390/nu11122839
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Obesity, a recognized risk factor for breast cancer in postmenopausal women, is associated with higher mortality rates regardless of menopausal status, which could in part be explained by therapeutic escape. Indeed, adipose microenvironment has been described to influence the efficiency of chemo- and hormonal therapies. Residual cancer stem cells could also have a key role in this process. To understand the mechanisms involved in the reduced efficacy of hormonal therapy on breast cancer cells in the presence of adipose secretome, human adipose stem cells (hMAD cell line) differentiated into mature adipocytes were co-cultured with mammary breast cancer cells and treated with hormonal therapies (tamoxifen, fulvestrant). Proliferation and apoptosis were measured (fluorescence test, impedancemetry, cytometry) and the gene expression profile was evaluated. Cancer stem cells were isolated from mammospheres made from MCF-7. The impact of chemo- and hormonal therapies and leptin was evaluated in this population. hMAD-differentiated mature adipocytes and their secretions were able to increase mammary cancer cell proliferation and to suppress the antiproliferative effect of tamoxifen, confirming previous data and validating our model. Apoptosis and cell cycle did not seem to be involved in this process. The evaluation of gene expression profiles suggested that STAT3 could be a possible target. On the contrary, leptin did not seem to be involved. The study of isolated cancer stem cells revealed that their proliferation was stimulated in the presence of anticancer therapies (tamoxifen, fulvestrant, doxorubicine) and leptin. Our study confirmed the role of adipocytes and their secretome, but above all, the role of communication between adipose and cancer cells in interfering with the efficiency of hormonal therapy. Among the pathophysiological mechanisms involved, leptin does not seem to interfere with the estrogenic pathway but seems to promote the proliferation of cancer stem cells.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Hormonal therapy in postmenopausal women with breast cancer
    Campos, SM
    Winer, EP
    ONCOLOGY, 2003, 64 (04) : 289 - 299
  • [32] Shifting paradigms in hormonal therapy for breast cancer
    Grana, G
    CANCER BIOLOGY & THERAPY, 2004, 3 (09) : 797 - 805
  • [33] Linkage Between Obesity Leptin and Breast Cancer
    Atoum, Manar Fayiz
    Alzoughool, Foad
    Al-Hourani, Huda
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2020, 14
  • [34] Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism
    Lyu, Xiaodan
    Zhang, Qian
    Fares, Hamza M.
    Wang, Yifan
    Han, Yi
    Sun, Li
    CANCER LETTERS, 2022, 534
  • [35] Mechanisms of endocrine therapy resistance in breast cancer
    Rasha, Fahmida
    Sharma, Monica
    Pruitt, Kevin
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 532
  • [36] Adjuvant hormonal therapy for early breast cancer: Assessment of patients' satisfaction
    Vardanega, Julie
    Henriques, Julie
    Pourcelot, Charlotte
    Dirand, Camille
    Nallet, Gilles
    Bredart, Anne
    Anota, Amelie
    Chaigneau, Loic
    Curtit, Elsa
    Limat, Samuel
    Paget-Bailly, Sophie
    Nerich, Virginie
    BULLETIN DU CANCER, 2019, 106 (12) : 1104 - 1114
  • [37] Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer
    Lumachi, Franco
    Santeufemia, Davide A.
    Fadda, Giovanni M.
    Tozzoli, Renato
    Chiara, Giordano B.
    Basso, Stefano M. M.
    MEDICINAL CHEMISTRY, 2016, 12 (03) : 261 - 267
  • [38] Adherence to long-term adjuvant hormonal therapy for breast cancer
    Gotay, Carolyn
    Dunn, Julia
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (06)
  • [39] Altered radiation responses of breast cancer cells resistant to hormonal therapy
    Luzhna, Lidiya
    Lykkesfeldt, Anne E.
    Kovalchuk, Olga
    ONCOTARGET, 2015, 6 (03) : 1678 - 1694
  • [40] Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives
    Barone, Ines
    Caruso, Amanda
    Gelsomino, Luca
    Giordano, Cinzia
    Bonofiglio, Daniela
    Catalano, Stefania
    Ando, Sebastiano
    OBESITY REVIEWS, 2022, 23 (02)